Accelerated Approval Transparency Act
Summary
Accelerated Approval Transparency Act This bill requires the Food and Drug Administration to include a summary of the reasons a drug or biologic received accelerated approval to treat a serious or life-threatening disease or condition in the public action package for the drug or biologic.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jun 2022
Committee Review
Floor Vote
President
Introduced Jun 14, 2022
Last action Jun 14, 2022
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
1
Jun 14, 2022
Committee
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
upper
Jun 14, 2022
Introduced
Introduced in Senate
upper
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
John W. Hickenlooper
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about S 4390
Scope: US
Hi! I can help you understand S 4390. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline